Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Artivion Inc AORT

Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment... see more

Recent & Breaking News (NYSE:AORT)

CryoLife to Present at 25th Annual Piper Jaffray Healthcare Conference

PR Newswire November 25, 2013

CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2013

PR Newswire November 21, 2013

CryoLife To Host Second Central Venous Pathology Summit in 2013

PR Newswire November 5, 2013

CryoLife Third Quarter 2013 Revenues Increase 8 Percent to a Record $36.3 Million

PR Newswire October 29, 2013

CryoLife Receives $15.4 Million Payment for its Shares of Medafor, Inc.

PR Newswire October 24, 2013

CryoLife Announces Release Date and Teleconference Call Details for 2013 Third Quarter Financial Results

PR Newswire October 14, 2013

CryoLife to Receive Approximately $15.1 Million from Acquisition of Medafor, Inc. by C. R. Bard, Inc.

PR Newswire October 7, 2013

CryoLife To Host Aortic Valve and Root Training Session

PR Newswire September 16, 2013

CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2013

PR Newswire August 21, 2013

CryoLife Announces First European Implant Of HeRO Graft

PR Newswire July 31, 2013

Biz-Dev Execs From GBS Consults LLC Say Emerging Medtech Companies Can Get Strategics' Attention Before They Are "De-Risked"

Business Wire July 25, 2013

CryoLife Reports Record Second Quarter Revenues

PR Newswire July 25, 2013

CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results

PR Newswire July 11, 2013

CryoLife Receives FDA Premarket Approval (PMA) for New Sologrip Minimally Invasive TMR Laser Fiber-Optic Delivery System

PR Newswire July 10, 2013

CryoLife Enhances International Presence with Appointment of Andres Sarmiento as Latin America Sales Manager

PR Newswire July 9, 2013

CryoLife Receives Conditional IDE Approval to Begin Clinical Trials for PerClot® in the U.S.

PR Newswire June 19, 2013

CryoLife Receives CE Mark For HeRo® Graft

PR Newswire June 10, 2013

CryoLife Increases Quarterly Cash Dividend 10 Percent for the Second Quarter 2013

PR Newswire May 28, 2013

CryoLife 2013 First Quarter Revenues Grew 10 Percent to a Record $35.5 Million

PR Newswire April 30, 2013

CryoLife Announces Release Date and Teleconference Call Details for 2013 First Quarter Financial Results

PR Newswire April 9, 2013